Searched for
ULLAS KAMATH
Buy Wonderla Holidays, target price Rs 425: Sharekhan by BNP ParibasWonderla Holidays, incorporated in the year 2002, is a Small Cap company (having a market cap of Rs 1963.73 Crore) operating in Tourism & H...
Snapdeal appoints Ullas Kamath and Anisha Motwani as directors on boardThe company is considering filing a draft red herring prospectus (DRHP) in the next few months, joining a growing list of startups preparin...
FMCG companies log sales growth after Unlock 2.0Unlock 2.0 has also increased the convenience of business for companies as earlier distribution was limited to certain hours in a day in se...
Clocking double-digit growth since first lockdown amid positive trends: Ullas Kamath, Jyothy Labs"All our manufacturing facilities barring one are functioning at 100% capacity. Demand both from rural and urban is intact and rural contin...
Brand loyalty takes a back seat: Pandemic pushes homemakers to try out new brandsA study by EY on the impact of Covid on homemakers reveals that a little more than half (53 per cent) tried a new brand during the pandemic...
Vision Group proposes to set up FMCG cluster to transform Hubli-Dharwad into hubVision Group Chairman Ullas Kamath submitted the report to Large and Small Scale Industries Minister Jagadish Shettar on Friday. The docume...
Jyothy Labs H2 will be far better than H1: Ullas KamathJyothi Labs, promoters will be debt-free by March 31, 2020, says Joint MD.
Jyothy Labs expects to be debt free by March 2021: Ullas KamathPromoters sell 4% stake to raise Rs 260 crore to reduced pledged shares to 6%
We are growing in double-digits since last six months: Ullas Kamath, Jyothi LabsJyothi Labs did not suffer from the demonetisation effect as we saw a volume growth of 5 per cent last year.
There is a feel-good factor post GST: Ullas Kamath, Jyothy LaboratoriesIt is far,far better now for FMCG in the post GST era, says the Jt MD of Jyothy Laboratories.
GST is the best thing any FMCG company could have asked for: K Ullas Kamath, Joint MD, Jyothy LabThe differential tax will be about 4% in our company and we will be able to like absorb that because of various consumer offers:K Ullas Kam...
Our internal growth target is 10%-12%: Ullas Kamath, Jyothy LaboratoriesIt will be better than what it used to be and now that rainfall is more than normal, in the coming quarters we will be able to do much bett...
Henkel, if at all, will come in as strategic investor: Ullas Kamath, Jyothy LabsWindow has been kept open till March 2017 for Henkel to exercise option for 26% in Jyothi Labs
Overall profit growth driven by mosquito repellent business: Ullas Kamath, Jyothy Laboratories"One of the reason is that the mosquito repellent business is doing extremely well, and Margo is doing well."
Expect top line to see 10-12% growth in next two quarters: Ullas Kamath, Jyothy Laboratories Ltd" For us, we got about 5 per cent to 6 per cent benefit because of the crude price down"
Jyothy Labs raises Rs 263 crore via preferential allotmentJyothy Laboratories Ltd (JLL) today said it has raised Rs 263 crore via preferential allotment of shares to a promoter Group firm.
- No plans to raise any funds via debt or equity route: Ullas Kamath, Jyothy Laboratories
Ullas Kamath, Dy MD, Jyothy Laboratories in an interview with ET Now talks about the quarterly results and product strategy for the company...
- Board to take a final decision on Jyothy Lab, Henkel: Ullas Kamath
In an interview with ET Now, Ullas Kamath, MD, Jyothy Laboratories, talks about the Open offer. Excerpts:
- Jyothy Labs to start open offer for Henkel India next week
Jyothy Laboratories said it will start the mandatory open offer by next week for 20% in Henkel India following its acquisition of majority ...
- Jyothy Labs to raise up to Rs 305 cr through IPO
Jyothy Laboratories plans to raise up to Rs 305 crore through an initial public offer and said it is open to acquire companies in future to...